Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in Elderly Advanced NSCLC
NCT00200395Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jul 2003
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Montefiore Medical Center. Primary endpoint: Rate of Response. Started Jul 2003; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00200395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200395.